Enteral nutrition has become an accepted method of providing nutritional support to malnourished patients with a functioning gastrointestinal tract. The most widely used administration technique is 24 hour infusion of a formulated enteral diet, with or without the use of a peristaltic pump, through a nasal fine bore feeding tube positioned in the stomach or upper small intestine.
One of the aims of nutritional support is to place patients in positive nitrogen balance. Attention has, therefore, been recently focused on the qualitative and quantitative characteristics of the nitrogen source of enteral diets. In patients with normal, or near normal, gastrointestinal function, there is no justification for prescribing enteral diets with other than a whole protein based nitrogen source,2 moreover, it is the quantity of whole protein prescribed which most commonly determines whether positive nitrogen balance is achieved. Patients were randomised to receive 2 25 1 of either a predigested enteral diet or an equinitrogenous and equicaloric quantity of polymeric diet in a seven day double blind crossover study. The predigested diet (Reabilan, Laboratories Sopharga, Puteaux, France) contained a milk protein derived oligopeptide nitrogen source prepared by the action of trypsin and chymotrypsin on whey proteins (one third) and casein (one third) using an industrial continuous enzymic membrane reactor technique at 38°C. The remaining one third was composed of a mixture of non-phosphorylated peptides extracted from the casein hydrolysate. The nonprotein energy source of the predigested diet comprised glucose polymers (60 3%), medium chain triglycerides (15-8%), essential fatty acids (14.3%), and long chain triglycerides (9.6%). The polymeric enteral diet was prepared in the hospital diet kitchen by adding 112.5 g Caloreen glucose polymer to 4 5 x 375 ml cans of Clinifeed 400 (Roussel Laboratories Ltd, Wembley, Middlesex) and making the final volume up to 2.25 1 with sterile distilled water. Clinifeed 400 is also a whole milk protein containing enteral diet, while glucose polymers and long chain triglycerides constitute the energy sources. The compositions of the two enteral diets are summarised in Table II . Both nitrogen sources consisted of casein and whey proteins, and their respective amino acid compositions would have been very similar and well balanced nutritionally.
The peptide chain length of the partial enzymic hydrolysate of milk proteins was determined using ligand exchange chromatography with Cu (11)-Sephadex as described previously.8 Approximately one third of amino nitrogen was in the form of di-and tripeptides, while oligopeptides of chain length greater than four amino acid residues comprised 62% of the milk protein hydrolysate (see Table III ).
TECHNIQUE OF ADMINISTRATION
Patients 6 and 7 had surgically fashioned jejunostomies. The remainder were intubated with a fine bore (2.1 mm od, 1-37 mm id) nasogastric feeding tube (Corpak Co, Wheeling, I1, USA).
The aim was to administer daily at least 2 25 1 study, in which each patient acted as their own control. Both enteral diets were equally well tolerated in that only two patients were withdrawn from the study on account of gastrointestinal side effects (diarrhoea), one each on commencing the peptide and whole protein containing enteral diets. In addition, patient 9, with jejunal diverticulosis, was relatively intolerant ofthe polymeric diet. It must be born in mind, however, that the two test enteral diets differed in fat content and composition, as well as nitrogen formulation, and this aspect could have affected gastrointestinal tolerance. Positive nitrogen balance was achieved with both diets in seven of 10 patients, with a mean intake of approximately 10 g nitrogen/d; and when considering all patients, there was no nutritional advantage from feeding the peptide based nitrogen source. Closer examination of the data, however, revealed that in three patients, 9, 10, and 12, better net nitrogen absorption and nitrogen balance occurred with the peptide, rather than the whole protein, based enteral diet (Table V) . Before discussing this apparent nutritional benefit from feeding oligopeptides in these patients, consideration should be given to three factors in the design of the present study.
The first is the period of time allowed for the study periods. Balance studies in healthy volunteers have revealed the presence of time dependent adaptations of the gastrointestinal tract to liquid defined formula diets, after normal solid food.'213 Gastrointestinal adaptation appears to take longer than seven days. Long study periods are not practical for most hospital patients and the randomised crossover design of the present study, where each patient acted as their own control, should have allowed for any physiological variables. Interpretation of the present data, however, must be seen in the context of a short term study.
Second, it is possible that the present results were prejudiced by the nature of the predigested nitrogen source tested. From recent in vivo jejunal perfusion studies in our laboratory, it has been observed that mucosal brush border hydrolysis is rate limiting with respect to nitrogen uptake from oligopeptides; and that subtle increases in peptide chain length from 2-3 to 3-5 amino acid residues have a significantly deleterious effect on a-amino acid nitrogen absorption.8 These data therefore indicate that in order to promote maximum absorption of a-amino acid nitrogen per unit length of intestine, consideration should be given to using a predigested dietary nitrogen preparation that contains a preponderance of di-and tripeptides. In the present study, small peptides of 2 to 3 amino acid residue comprised only about one third of dietary nitrogen supplied by the peptide based diet (Table III) .
Further examination of the data indicates, however, that for the majority of patients, it is highly unlikely that any possible nutritional advantage from using the partial enzymic hydrolysate could have been precluded by the peptide chain length profile. With both enteral diets, mean net nitrogen absorption and total stool nitrogen were approximately 90% and 1 g nitrogen/d respectively (Tables IV and V) . The latter value is no greater than that found for endogenous nitrogen losses alone from the human small bowel in healthy subjects.4 Thus, even allowing for subsequent colonic salvage of nitrogen through fermentation to ammonia,'5 the present results indicate that, in most patients, both nitrogen sources were very well absorbed in the small bowel.
The last issue is whether the extent of gastrointestinal disease or dysfunction present in the patients studied, would have been likely to have measurably impaired the assimilation of whole protein. The reserve capacity of gastrointestinal function for nutrient assimilation is large. Studies in normal subjects have shown that the bulk of ingested protein appears to be absorbed in the proximal jejunum.'6 Also, it appears that in the presence of normal gastrointestinal function, up to 90% impairment of exocrine pancreatic function has to occur before luminal hydrolysis becomes rate limiting to the assimila- Thus, when considered as a group, there appeared to be no indication for prescribing an enteral diet with a predigested nitrogen source to patients perceived to have moderately impaired gastrointestinal function. It did emerge, however, that patients 9, 10, and 12, whose net absorption of nitrogen was relatively better from the peptide based enteral diet, may represent a clinically identifiable sub group of patients with clinically significant malabsorption. In these patients, who had small bowel disease (jejunal diverticulosis, amyloidosis and ileocolonic Crohn's disease respectively (Table I) ), intestinal mucosal absorptive reserve capacity appears to have been sufficiently impaired for the oligopeptide nitrogen source to have had a nutritional advantage over whole protein.
In conclusion, these results indicate that the prescribing of enteral diets containing a predigested nitrogen source, in order to achieve positive nitrogen balance, is not indicated in the majority of patients with moderately impaired gastrointestinal function. There appears to be a subgroup of patients, characterised by specific small bowel disease, however, who may require short chain peptides, preferably di-and tripeptides, rather than whole protein for optimum nitrogen absorption.
